CTEV logo

CTEV

NA

$37.45
-$1.51(-3.88%)
31
Overall
40
Value
18
Tech
36
Quality
Market Cap
$561.87M
Volume
148.05K
52W Range
$5.61 - $74.07
Target Price
$85.00

Company Overview

Mkt Cap$561.87MPrice$37.45
Volume148.05KChange-3.88%
P/E Ratio-0.3Open$39.00
Revenue$930.6MPrev Close$38.96
Net Income$-1.6B52W Range$5.61 - $74.07
Div YieldN/ATarget$85.00
Overall31Value40
Quality36Technical18

No chart data available

About NA

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.

Latest News

Piper Sandler Reaffirms Their Buy Rating on Claritev (CTEV)

Piper Sandler analyst Jessica Tassan maintained a Buy rating on Claritev today and set a price target of $90.00. According to TipRanks, Tassan is a...

TipRanks Auto-Generated Intelligence Newsdeska month ago
ABCD
1SymbolPriceChangeVol
2CTEV$37.45-3.9%148.05K
3
4
5
6

Get NA Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.